09/2023

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

09/2023

Sep 24, 2023, 18:40 | Blog
We Did It! Tricycle Tour For Kids With Cancer is Now Complete! - SIOP Europe, the European Society for Paediatric Oncology (SIOPE)
SIOP Europe, the European Society for Paediatric Oncology (SIOPE), recently shared on LinkedIn: "We Did…
Sep 24, 2023, 18:33 | Blog
Welcoming American Oncology Network to the Closing Bell in celebration of their listing on Nasdaq Exchange - Nasdaq Exchange
Nasdaq Exchange, recently shared on Twitter: "Welcoming American Oncology Network to the Closing Bell in celebration…
Sep 24, 2023, 18:28 | Blog
Eric Bouffet: Paediatric Oncology makes the Head Line at the UN general assembly!
Eric Bouffet, Head of the Neuro-Oncology Section in the Division of Haematology/Oncology at The Hospital…
Sep 24, 2023, 18:21 | Insight
Eytan Ruppin: We present IRIS: a machine-learning method aimed at identifying candidate ligand-receptor interactions that are likely to mediate immune checkpoint blockade resistance in the tumor microenvironment.
Sep 24, 2023, 18:13 | Blog
Tedros Adhanom Ghebreyesus: The 5 year celebration of the WHO Global Initiative for Childhood Cancer and the impact it’s made left us with great hope at UN General Assembly today.
Sep 24, 2023, 18:10 | Stories
Sachin H. Jain: Take your vacations. Don’t be a martyr. Almost no one notices your martyrdom.
Quoting Sachin H. Jain, President and CEO of SCAN Group and Health Plan, on LinkedIn: “Several…
Sep 24, 2023, 18:03 | Blog
Pashtoon Murtaza Kasi: The imagery at RareCyte Incorporated will blow your mind.
Quoting Pashtoon Murtaza Kasi, Oncologist and Researcher at Weill Cornel Medicine and New York- Presbyterian…
Sep 24, 2023, 17:59 | Blog
Amar Gajjar: We find ourselves in the “golden era” of tumor molecular biology and targeted therapy.
Quoting Amar Gajjar, Paediatric Neuro-Oncologist at St.Jude Research Hospital, on X/Twitter: “We find ourselves in…
Sep 24, 2023, 17:52 | Blog
Vivek Subbiah: Great honor to meet with the amazing and beloved The Nobel Prizewinner Dr. Bill Kaelin Dana-Farber Cancer Institute.
Vivek Subbiah, Chief, Early-Phase Drug Development at Sarah Cannon Research Institute, shared on LinkedIn: ''Great…
Sep 24, 2023, 17:45 | Blog
Lisa Lacasse: One word to explain the last few days – phenomenal...
Quoting Lisa Lacasse, the President of the American Cancer Society Cancer Action Network (ACS CAN),…
All: 695 Posts: 161 - 170